Cytotoxicity of oncolytic herpes simplex virus vector of breast cancer stem cells.

被引：0
|
作者：
Li, J.
Liu, R.
Wang, J.
Rabkin, S. D.
机构：
[1] Sun Yat Sen Univ, Affiliated Hosp 3, Breast Canc Ctr, Guangzhou 510275, Guangdong, Peoples R China
[2] Sun Yat Sen Univ, Affiliated Hosp 3, Guangzhou 510275, Guangdong, Peoples R China
[3] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Mol Neurosurg Lab, Boston, MA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
10.1200/jco.2010.28.15_suppl.e13637
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e13637
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Treatment of human breast tumors by oncolytic herpes simplex virus.
    Liu, R.
    Wang, J.
    Li, J.
    Rabkin, S. D.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [32] Disabled infectious single-cycle herpes simplex virus as an oncolytic vector for immunotherapy of colorectal cancer
    Todryk, S
    McLean, C
    Ali, S
    Entwistle, C
    Boursnell, M
    Rees, R
    Vile, R
    HUMAN GENE THERAPY, 1999, 10 (17) : 2757 - 2768
  • [33] Oncolytic herpes simplex virus vectors effectively kill human glioblastoma stem-like cells
    Wakimoto, Hiroaki
    Farrell, Christopher
    Aghi, Manish
    Martuza, Robert
    Rabkin, Samuel
    NEURO-ONCOLOGY, 2007, 9 (04) : 597 - 598
  • [34] Delivery of Oncolytic Herpes Simplex Virus to Infiltrative Brain Tumor Sites Via Neuronal Stem Cells
    Voss, Tyler T.
    Bobbitt, Kevin R.
    Brodie, Chaya
    Synder, Evan
    Miller, Cathie G.
    MOLECULAR THERAPY, 2006, 13 : S411 - S411
  • [35] Therapeutic targeting of chemoresistant and recurrent glioblastoma stem cells with a proapoptotic variant of oncolytic herpes simplex virus
    Jahan, Nusrat
    Lee, Jae M.
    Shah, Khalid
    Wakimoto, Hiroaki
    INTERNATIONAL JOURNAL OF CANCER, 2024, 155 (05) : E6 - E6
  • [36] Therapeutic targeting of chemoresistant and recurrent glioblastoma stem cells with a proapoptotic variant of oncolytic herpes simplex virus
    Jahan, Nusrat
    Lee, Jae M.
    Shah, Khalid
    Wakimoto, Hiroaki
    INTERNATIONAL JOURNAL OF CANCER, 2017, 141 (08) : 1671 - 1681
  • [37] Restriction of Replication of Oncolytic Herpes Simplex Virus with a Deletion of γ34.5 in Glioblastoma Stem-Like Cells
    Peters, Cole
    Paget, Max
    Tshilenge, Kizito-Tshitoko
    Saha, Dipongkor
    Antoszczyk, Slawomir
    Baars, Anouk
    Frost, Thomas
    Martuza, Robert L.
    Wakimoto, Hiroaki
    Rabkin, Samuel D.
    JOURNAL OF VIROLOGY, 2018, 92 (15)
  • [38] RE: Stem Cells Loaded with Multimechanistic Oncolytic Herpes Simplex Virus Variants for Brain Tumor Therapy
    Krause, Marie N.
    Sancho-Martinez, Ignacio
    Belmonte, Juan Carlos Izpisua
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2015, 107 (01):
  • [39] Oncolytic herpes simplex virus vectors and taxanes synergize to promote killing of prostate cancer cells
    Passer, B. J.
    Castelo-Branco, P.
    Buhrman, J. S.
    Varghese, S.
    Rabkin, S. D.
    Martuza, R. L.
    CANCER GENE THERAPY, 2009, 16 (07) : 551 - 560
  • [40] Oncolytic herpes simplex virus infects myeloma cells in vitro and in vivo
    Ghose, Jayeeta
    Dona, Ada
    Murtadha, Mariam
    Gunes, Emine Gulsen
    Caserta, Enrico
    Yoo, Ji Young
    Russell, Luke
    Jaime-Ramirez, Alena Cristina
    Barwick, Benjamin G.
    Gupta, Vikas A.
    Sanchez, James F.
    Sborov, Douglas W.
    Rosen, Steven T.
    Krishnan, Amrita
    Boise, Lawrence H.
    Kaur, Balveen
    Hofmeister, Craig C.
    Pichiorri, Flavia
    MOLECULAR THERAPY-ONCOLYTICS, 2021, 20 : 519 - 531
12345